Tremlett H - Search Results

1

The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.

Kowalec K, Carleton B, Tremlett H. Kowalec K, et al. Among authors: tremlett h. Mult Scler Relat Disord. 2013 Jul;2(3):183-92. doi: 10.1016/j.msard.2012.11.003. Epub 2013 Jan 10. Mult Scler Relat Disord. 2013. PMID: 25877724 Review.

2

Elevated aminotransferases during treatment with interferon-beta for multiple sclerosis: actions and outcomes.

Tremlett HL, Oger J. Tremlett HL, et al. Mult Scler. 2004 Jun;10(3):298-301. doi: 10.1191/1352458504ms1007oa. Mult Scler. 2004. PMID: 15222695

3

Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective.

Tremlett HL, Oger J. Tremlett HL, et al. Mult Scler. 2008 Jan;14(1):94-105. doi: 10.1177/1352458507079658. Epub 2007 Sep 19. Mult Scler. 2008. PMID: 17881392

4

Natural history of secondary-progressive multiple sclerosis.

Tremlett H, Yinshan Zhao, Devonshire V. Tremlett H, et al. Mult Scler. 2008 Apr;14(3):314-24. doi: 10.1177/1352458507084264. Epub 2008 Jan 21. Mult Scler. 2008. PMID: 18208898

5

Disease onset in familial and sporadic primary progressive multiple sclerosis.

Koch M, Zhao Y, Yee I, Guimond C, Kingwell E, Rieckmann P, Sadovnick D, Tremlett H; UBC MS Clinic Neurologists. Koch M, et al. Among authors: tremlett h. Mult Scler. 2010 Jun;16(6):694-700. doi: 10.1177/1352458510367661. Epub 2010 Apr 8. Mult Scler. 2010. PMID: 20378663

6

High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: a longitudinal study.

Chan S, Kingwell E, Oger J, Yoshida E, Tremlett H. Chan S, et al. Among authors: tremlett h. Mult Scler. 2011 Mar;17(3):361-7. doi: 10.1177/1352458510388823. Epub 2010 Dec 10. Mult Scler. 2011. PMID: 21148660

7

Natural, innate improvements in multiple sclerosis disability.

Tremlett H, Zhu F, Petkau J, Oger J, Zhao Y; BC MS Clinic Neurologists. Tremlett H, et al. Mult Scler. 2012 Oct;18(10):1412-21. doi: 10.1177/1352458512439119. Epub 2012 Jun 26. Mult Scler. 2012. PMID: 22736751

8

Labor induction and augmentation in women with multiple sclerosis.

Lu E, Zhu F, van der Kop M, Dahlgren L, Synnes A, Sadovnick A, Traboulsee A, Tremlett H; British Columbia Multiple Sclerosis Clinic Neurologists. Lu E, et al. Among authors: tremlett h. Mult Scler. 2013 Aug;19(9):1182-9. doi: 10.1177/1352458512474090. Epub 2013 Feb 5. Mult Scler. 2013. PMID: 23386429

9

Birth outcomes of pregnancies fathered by men with multiple sclerosis.

Lu E, Zhu F, Zhao Y, van der Kop M, Sadovnick AD, Synnes A, Dahlgren L, Traboulsee A, Tremlett H. Lu E, et al. Among authors: tremlett h. Mult Scler. 2014 Aug;20(9):1260-4. doi: 10.1177/1352458514521308. Epub 2014 Feb 5. Mult Scler. 2014. PMID: 24500603

10

Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients.

Kowalec K, Kingwell E, Yoshida EM, Marrie RA, Kremenchutzky M, Campbell TL, Wadelius M, Carleton B, Tremlett H. Kowalec K, et al. Among authors: tremlett h. Expert Opin Drug Saf. 2014 Oct;13(10):1305-17. doi: 10.1517/14740338.2014.947958. Epub 2014 Aug 18. Expert Opin Drug Saf. 2014. PMID: 25134421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

252 results

Search Page